News for Healthier Living

Psilera Greenlit to Initiate Phase 2 of NIH Grant for Alcohol Use Disorder

Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, today announced the initiation of Phase 2 of its SBIR NIH-backed research into Alcohol Use Disorder (AUD).

October 8, 2026


October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026